Doctors without Borders asks J&J not to enforce secondary patents for TB drug after generic deal with nonprofit

Doctors without Borders criticized a deal between Johnson & Johnson and the Stop TB Partnership that allows the Swiss nonprofit to manufacture and supply generic forms of J&J’s tuberculosis drug, Sirturo.

The patent for Sirturo, or bedaquiline, expired Tuesday in multiple countries, according to Médecins Sans Frontières (MSF), the medical advocacy group also known as Doctors Without Borders.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Graphene biosensor offers accurate assessment of meat freshness

The freshness of animal meat is an essential property determining its quality and safety. With advanced technology capable of preserving food for extended periods of

February 20, 2024

Canadian Cannabis Sales Slump

Statistics Canada released January retail sales for the country, with cannabis sales decreasing from the December levels, down 11.5% to C$400.7 million. December was revised higher to

March 22, 2024

PanTera raises €93M to ‘radically improve supply’ of actinium for radiotherapeutics

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.